CME Stock Chart & Stats
$4468.00
$0.00(0.00%)
At close: 4:00 PM EDT
$4468.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3,709.81 - $6,000.00
Previous CloseN/A
Volume0.00
Average Volume (3M)142.00
Market Cap
$1.68T
Enterprise Value$81.37K
Total Cash (Recent Filing)$2.28B
Total Debt (Recent Filing)$3.42B
Price to Earnings (P/E)23.3
Beta-0.21
Next Earnings
Oct 21, 2026EPS Estimate
49.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.85
Shares Outstanding359,576,100
10 Day Avg. Volume0
30 Day Avg. Volume142
Financial Highlights & Ratios
PEG Ratio1.59
Price to Book (P/B)3.42
Price to Sales (P/S)15.06
P/FCF Ratio23.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4,653.92Price Target Upside4.16% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)208.24
Revenue Forecast (FY)$119.32B
Bulls Say, Bears Say
Bulls Say
Exceptional ProfitabilityCME’s exceptionally high profitability indicates a scalable exchange and clearing model with substantial operating leverage. Strong margins provide resources for technology investment, product development, regulatory compliance and shareholder returns, helping preserve competitive strength across the next several quarters.
Durable Trading And Data GrowthGrowth across market data and transaction activity demonstrates that CME is expanding beyond a single volume stream. Recurring information revenue, rising derivatives usage and broader product adoption should support more resilient revenue generation as customer risk-management needs evolve.
Strong Financial FlexibilityLow leverage gives CME meaningful financial flexibility while its substantial cash generation supports investment, dividends, buybacks and strategic initiatives. This balance-sheet strength can help the company absorb market or regulatory changes without depending heavily on external financing.
Bears Say
Regulatory Rollout UncertaintyRegulatory intervention can delay or reshape new products, slowing the conversion of CME’s innovation pipeline into revenue. Uncertainty around approvals and litigation also raises execution costs and may limit the pace at which expanded trading access contributes to growth.
Margin CompressionRecent margin compression suggests that part of CME’s strong earnings growth is not translating into fully preserved profitability. If lower margins persist, they could reduce operating leverage, constrain incremental earnings conversion and make future results more dependent on sustained volume growth.
Volatile Free-cash-flow GrowthAlthough absolute cash generation remains strong, unstable year-over-year free-cash-flow growth makes underlying cash conversion less predictable. Period-specific movements can complicate planning for capital returns and investment, increasing uncertainty around the durability of reported cash-flow performance.
CME Group News
CME FAQ
What was CME Group’s price range in the past 12 months?
CME Group lowest stock price was $3709.81 and its highest was $6000.00 in the past 12 months.
What is CME Group’s market cap?
CME Group’s market cap is $1.68T.
When is CME Group’s upcoming earnings report date?
CME Group’s upcoming earnings report date is Oct 21, 2026 which is in 38 days.
How were CME Group’s earnings last quarter?
CME Group released its earnings results on Jul 22, 2026. The company reported $50.741 earnings per share for the quarter, beating the consensus estimate of $49.298 by $1.442.
Is CME Group overvalued?
According to Wall Street analysts CME Group’s price is currently Undervalued.
Does CME Group pay dividends?
CME Group does not currently pay dividends.
What is CME Group’s EPS estimate?
CME Group’s EPS estimate is 49.82.
How many shares outstanding does CME Group have?
CME Group has 359,576,100 shares outstanding.
What happened to CME Group’s price movement after its last earnings report?
CME Group reported an EPS of $50.741 in its last earnings report, beating expectations of $49.298. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CME Group?
Currently, no hedge funds are holding shares in MX:CME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CME Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4,653.92 (4.16% Upside)
$4,653.92 (4.16% Upside)
Blogger Sentiment
Neutral
MX:CME Sentiment 53%
Sector Average 58%
Sector Average 58%
Insider Transactions
Sold Shares
Worth $70.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 63%
Bearish news 38%
Bearish news 38%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.09%
12-Months-Change
Fundamentals
Return on Equity
4.11%
Trailing 12-Months
Asset Growth
8.21%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CME Group
CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.
CME Company Deck
CME Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial performance: record Q2 revenue for the quarter, robust ADV and open interest growth, healthy margins, sizeable shareholder returns, and a clear pipeline of product innovation (24/7 trading, Single Stock futures, Compute Futures, Treasury Link). The principal negatives were regulatory uncertainty (CFTC stay and pending litigation), strategic caution and market-risk concerns around perpetual futures, and early-stage monetization for prediction markets. On balance, the positive execution, growth trends and product roadmap materially outweigh the regulatory and product-structure headwinds.View all MX:CME earnings summariesCME Revenue Breakdown
80.99% Clearing and transaction fees
12.32% Market data and information services
6.69% Other

CME Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$4,653.92
▲(4.16% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cboe Global Markets
―
Intercontinental Exchange
―
S&P Global
―
Nasdaq
―
Coinbase Global
―












